IL-17RA Signaling in Prx1+ Mesenchymal Cells Influences Fracture Healing in Mice
- PMID: 38612562
- PMCID: PMC11011315
- DOI: 10.3390/ijms25073751
IL-17RA Signaling in Prx1+ Mesenchymal Cells Influences Fracture Healing in Mice
Abstract
Fracture healing is a complex series of events that requires a local inflammatory reaction to initiate the reparative process. This inflammatory reaction is important for stimulating the migration and proliferation of mesenchymal progenitor cells from the periosteum and surrounding tissues to form the cartilaginous and bony calluses. The proinflammatory cytokine interleukin (IL)-17 family has gained attention for its potential regenerative effects; however, the requirement of IL-17 signaling within mesenchymal progenitor cells for normal secondary fracture healing remains unknown. The conditional knockout of IL-17 receptor a (Il17ra) in mesenchymal progenitor cells was achieved by crossing Il17raF/F mice with Prx1-cre mice to generate Prx1-cre; Il17raF/F mice. At 3 months of age, mice underwent experimental unilateral mid-diaphyseal femoral fractures and healing was assessed by micro-computed tomography (µCT) and histomorphometric analyses. The effects of IL-17RA signaling on the osteogenic differentiation of fracture-activated periosteal cells was investigated in vitro. Examination of the intact skeleton revealed that the conditional knockout of Il17ra decreased the femoral cortical porosity but did not affect any femoral trabecular microarchitectural indices. After unilateral femoral fractures, Il17ra conditional knockout impacted the cartilage and bone composition of the fracture callus that was most evident early in the healing process (day 7 and 14 post-fracture). Furthermore, the in vitro treatment of fracture-activated periosteal cells with IL-17A inhibited osteogenesis. This study suggests that IL-17RA signaling within Prx1+ mesenchymal progenitor cells can influence the early stages of endochondral ossification during fracture healing.
Keywords: IL-17A; cytokine; inflammation; periosteum; secondary bone healing.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.Bone. 2016 Jul;88:20-30. doi: 10.1016/j.bone.2016.04.005. Epub 2016 Apr 19. Bone. 2016. PMID: 27102547 Free PMC article.
-
Rosiglitazone induces adipogenesis of both marrow and periosteum derived mesenchymal stem cells during endochondral fracture healing.J Orthop Sci. 2023 Mar;28(2):460-467. doi: 10.1016/j.jos.2021.11.005. Epub 2021 Dec 6. J Orthop Sci. 2023. PMID: 34879982 Free PMC article.
-
Periosteum progenitors could stimulate bone regeneration in aged murine bone defect model.J Cell Mol Med. 2020 Oct;24(20):12199-12210. doi: 10.1111/jcmm.15891. Epub 2020 Sep 15. J Cell Mol Med. 2020. PMID: 32931157 Free PMC article.
-
Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.Bone. 2016 Oct;91:64-74. doi: 10.1016/j.bone.2016.07.006. Epub 2016 Jul 12. Bone. 2016. PMID: 27416809 Free PMC article.
-
Osteogenic Differentiation of Periosteal Cells During Fracture Healing.J Cell Physiol. 2017 May;232(5):913-921. doi: 10.1002/jcp.25641. Epub 2016 Oct 26. J Cell Physiol. 2017. PMID: 27731505 Free PMC article. Review.
Cited by
-
The dual role of IL-17 in periodontitis regulating immunity and bone homeostasis.Front Immunol. 2025 Apr 3;16:1578635. doi: 10.3389/fimmu.2025.1578635. eCollection 2025. Front Immunol. 2025. PMID: 40248692 Free PMC article. Review.
References
-
- Global Burden of Disease 2019 Fracture Collaborators Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2:e580–e592. doi: 10.1016/S2666-7568(21)00172-0. - DOI - PMC - PubMed
-
- Duchamp de Lageneste O., Julien A., Abou-Khalil R., Frangi G., Carvalho C., Cagnard N., Cordier C., Conway S.J., Colnot C. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat. Commun. 2018;9:773. doi: 10.1038/s41467-018-03124-z. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical